These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 3755554)
21. Percutaneous absorption of ibuprofen from different formulations. Comparative study with gel, hydrophilic ointment and emulsion cream. Seth PL Arzneimittelforschung; 1993 Aug; 43(8):919-21. PubMed ID: 8216453 [TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics and bioavailability of percutaneous ibuprofen. Kleinbloesem CH; Ouwerkerk M; Spitznagel W; Wilkinson FE; Kaiser RR Arzneimittelforschung; 1995 Oct; 45(10):1117-21. PubMed ID: 8595072 [TBL] [Abstract][Full Text] [Related]
23. Bioequivalence study of three ibuprofen formulations after single dose administration in healthy volunteers. Bramlage P; Goldis A BMC Pharmacol; 2008 Oct; 8():18. PubMed ID: 18959779 [TBL] [Abstract][Full Text] [Related]
24. Absorption of oral lornoxicam in healthy volunteers using a granular formulation in comparison with standard tablets. Bareggi SR; Gambaro V; Valenti M; Benvenuti C Arzneimittelforschung; 1997 Jun; 47(6):755-7. PubMed ID: 9239455 [TBL] [Abstract][Full Text] [Related]
25. Penbutolol and furosemide in a fixed-dose combination-bio-equivalence of two formulations. Meyer BH; Müller FO; Hundt HK; Grigoleit HG; Hajdu P; Heptner W S Afr Med J; 1981 Jun; 59(25):891-3. PubMed ID: 7015536 [TBL] [Abstract][Full Text] [Related]
26. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects. Ramael S; De Smedt F; Toublanc N; Otoul C; Boulanger P; Riethuisen JM; Stockis A Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095 [TBL] [Abstract][Full Text] [Related]
27. Assessment of bio(in)equivalence of deriphyllin-digoxin in human volunteers. Bansinath M; Ghosh SS; Shafiqa A; Shukla VK; Chopra KS; Mathur VS Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):30-3. PubMed ID: 3957487 [TBL] [Abstract][Full Text] [Related]
28. Distinct pharmacokinetic profile and safety of a fixed-dose tablet of sumatriptan and naproxen sodium for the acute treatment of migraine. Haberer LJ; Walls CM; Lener SE; Taylor DR; McDonald SA Headache; 2010 Mar; 50(3):357-73. PubMed ID: 20132340 [TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetic and taste evaluation of ibuprofen (Motrin) 800 mg tablets in extemporaneous solution. Small RE; Johnson SM; Willis HE J Rheumatol; 1988 Feb; 15(2):345-7. PubMed ID: 3361543 [TBL] [Abstract][Full Text] [Related]
30. Assessment of bio(in)equivalence of deriphyllin-digoxin in human volunteers. II. Evaluation of rabbits as qualitative animal model. Bansinath M; Ghosh SS; Shukla VK; Chopra KS; Mathur VS Methods Find Exp Clin Pharmacol; 1986 May; 8(5):303-7. PubMed ID: 3724304 [TBL] [Abstract][Full Text] [Related]
31. Comparison of two different preparations of ibuprofen with regard to the time course of their analgesic effect. A randomised, placebo-controlled, double-blind cross-over study using laser somatosensory evoked potentials obtained from UW-irritated skin in healthy volunteers. Seibel K; Schaffler K; Reeh P; Reitmeir P Arzneimittelforschung; 2004; 54(8):444-51. PubMed ID: 15460211 [TBL] [Abstract][Full Text] [Related]
32. Dose proportionality and the effects of food on bioavailability of an immediate-release oxycodone hydrochloride tablet designed to discourage tampering and its relative bioavailability compared with a marketed oxycodone tablet under fed conditions: a single-dose, randomized, open-label, 5-way crossover study in healthy volunteers. Bass A; Stark JG; Pixton GC; Sommerville KW; Zamora CA; Leibowitz M; Rolleri R Clin Ther; 2012 Jul; 34(7):1601-12. PubMed ID: 22717418 [TBL] [Abstract][Full Text] [Related]
33. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers. Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557 [TBL] [Abstract][Full Text] [Related]
34. Relative bioavailability of rapidly dispersing, plain, and microencapsuled acetylsalicylic acid tablets after single dose administration. Siegmund W; Hoffmann C; Zschiesche M; Steinijans VW; Sauter R; Krüger WD; Diedrich F Int J Clin Pharmacol Ther; 1998 Mar; 36(3):133-8. PubMed ID: 9562228 [TBL] [Abstract][Full Text] [Related]
35. Absolute bioavailability of oral theophylline. Hendeles L; Weinberger M; Bighley L Am J Hosp Pharm; 1977 May; 34(5):525-7. PubMed ID: 868891 [TBL] [Abstract][Full Text] [Related]
36. [Pharmacokinetics and bioequivalence of two ibuprofen formulations]. Lenhard G; Kieferndorf U; Berner G; Engels B; Vögtle-Junkert U Arzneimittelforschung; 1990 Dec; 40(12):1358-62. PubMed ID: 2095133 [TBL] [Abstract][Full Text] [Related]
37. Results of a single-center, single-dose, randomized-sequence, open-label, two-way crossover bioequivalence study of two formulations of valsartan 160-mg tablets in healthy volunteers under fasting conditions. Spínola AC; Almeida S; Filipe A; Neves R; Trabelsi F; Farré A Clin Ther; 2009 Sep; 31(9):1992-2001. PubMed ID: 19843489 [TBL] [Abstract][Full Text] [Related]
38. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects. Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728 [TBL] [Abstract][Full Text] [Related]
39. Application of guar gum biopolymer in the prescription of tablets with sodium ibuprofen--quality tests and pharmaceutical availability in vitro. Berner-Strzelczyk A; Kołodziejska J; Zgoda MM Polim Med; 2006; 36(4):3-11. PubMed ID: 17402228 [TBL] [Abstract][Full Text] [Related]
40. Comparative bioavailability study of two ibuprofen preparations after oral administration in healthy volunteers. Bienert A; Szkutnik-Fiedler D; Dyderski S; Grześkowiak E; Drobnik L; Wolc A; Slawińiska U Arzneimittelforschung; 2006; 56(9):647-51. PubMed ID: 17063640 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]